Low Resource Integrated Platform for Production and Analysis of Capped mRNA

[Image: see text] The existing platform for large-scale mRNA production is fast, but consumable costs, process technicality, and complexity represent key bottlenecks limiting global mRNA biologics manufacturing. Another challenge is the lack of a consolidated platform for mRNA product characterizati...

Descripción completa

Detalles Bibliográficos
Autores principales: Nwokeoji, Alison Obinna, Chou, Tachung, Nwokeoji, Eleojo Ahuva
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2022
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9872168/
https://www.ncbi.nlm.nih.gov/pubmed/36495278
http://dx.doi.org/10.1021/acssynbio.2c00609

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9872168/
https://www.ncbi.nlm.nih.gov/pubmed/36495278
http://dx.doi.org/10.1021/acssynbio.2c00609

Ejemplares similares